GENEVA, Switzerland (AFP) — Swiss pharmaceutical giant Roche said Tuesday that Japan had become the first country to fully approve its Ronapreve antibody treatment for patients with mild to moderate Covid-19. The approval was based on phase 3 trials finding that the antibody cocktail dramatically reduced the likelihood that mild or moderate Covid patients would develop into serious illness causing hospitalization or death. Ronapreve, developed in cooperation with US biotech firm Regeneron, was approved by […]